Universitäts-klinikum Würzburg
Welcome,         Profile    Billing    Logout  
 7 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nordbeck, Peter
NCT04840667 / 2018-004689-32: A Study of Replagal in Treatment-naïve Adults With Fabry Disease

Terminated
3
17
Europe, Canada
REPLAGAL, SHP675
Shire
Fabry Disease
12/22
12/22
STAAR, NCT04046224 / 2019-000667-24: Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease

Active, not recruiting
1/2
34
Europe, Canada, US, RoW
ST-920
Sangamo Therapeutics
Fabry Disease
04/25
09/25
AIM-ICD, NCT04264455: Evaluation of Long-term Incidence of Ventricular Arrhythmias in Patients With Acute Myocarditis

Recruiting
N/A
34
Europe
Biomonitor, Life Vest, Implantable Cardioverter-Defibrillator (ICD)
Wuerzburg University Hospital, MVZ Leopoldina GmbH, Brandenburg Medical School Theodor Fontane, Hannover Medical School
Myocarditis Acute, Ventricular Arrythmia
12/22
12/23
NCT03022851: The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension

Recruiting
N/A
30
Europe, RoW
Occlutech AFR Device
Occlutech International AB
Pulmonary Hypertension
02/23
12/23
DanShock, NCT01633502: Danish Cardiogenic Shock Trial

Completed
N/A
360
Europe
Conventional circulatory support, Conventional circulatory support will be employed according to enrolling sites usual management., Impella CP, Impella CP, Abiomed
Odense University Hospital, Aarhus University Hospital Skejby, Hannover Medical School, University Hospital, Bonn, Jena University Hospital, University Hospital Dresden, Heinrich-Heine University, Duesseldorf, Universitätsklinikum Hamburg-Eppendorf, Charite University, Berlin, Germany, Royal Brompton & Harefield NHS Foundation Trust, Wuerzburg University Hospital, Rigshospitalet, Denmark
Cardiogenic Shock Acute, Acute Myocardial Infarction
07/23
04/24
REDEAL-HF, NCT03966729: Relationships and Differences Analysis in Heart Failure

Recruiting
N/A
3000
Europe
Time (outcome)
Wuerzburg University Hospital
Heart Failure, Chronic Heart Failure, Chronic Heart Disease
12/23
12/23
MALTA-FABRY, NCT03683966: MigALastat Therapy Adherence Among FABRY Patients: A Prospective Multicentral Observational Study

Recruiting
N/A
30
Europe
Wuerzburg University Hospital, Charite University, Berlin, Germany, University Hospital Muenster, Health Care Center Dr. Markus Cybulla, Muellheim
Rare Diseases, Fabry Disease, Adherence, Medication, Quality of Life
12/23
12/23
NCT05425459: RESPONDER-HF Trial

Recruiting
N/A
750
Europe, Canada, US, RoW
Corvia Atrial Shunt System / IASD System II, Intra-cardiac echocardiography (ICE), or transesophageal echocardiography (TEE)
Corvia Medical
Heart Failure, Heart Failure, Diastolic
05/25
03/31
PRAETORIAN-DFT, NCT03495297: A Randomised Trial of S-ICD Implantation with and Without Defibrillation Testing

Active, not recruiting
N/A
965
Europe, US
ommitence of defibrillation testing
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Boston Scientific Corporation
Ventricular Arrythmia
04/25
07/25
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Recruiting
N/A
1252
Europe, Canada, US
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump
Abiomed Inc.
Left Ventricular Dysfunction, Coronary Artery Disease
03/26
10/27
GoPEG, NCT06095713: German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfa

Recruiting
N/A
60
Europe
Pegunigalsidase-alfa
Westfälische Wilhelms-Universität Münster, Chiesi GmbH
Fabry Disease
03/26
03/26
HEAL-FABRY, NCT03362164: Evaluation of HEArt invoLvement in Patients With FABRY Disease

Recruiting
N/A
650
Europe
Wuerzburg University Hospital, Competence Network Heart Failure, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), St George's, University of London
Rare Diseases, Fabry Disease, Fabry Disease, Cardiac Variant, Hypertrophic Cardiomyopathy
03/32
03/32

Download Options